Literature DB >> 18174447

Modified constraint-induced therapy in chronic stroke: results of a single-blinded randomized controlled trial.

Stephen J Page1, Peter Levine, Anthony Leonard, Jerzy P Szaflarski, Brett M Kissela.   

Abstract

BACKGROUND AND
PURPOSE: This single-blinded randomized controlled trial compared the efficacy of a reimbursable, outpatient, modified constraint-induced therapy (mCIT) protocol (half-hour therapy sessions occurring 3 days per week in which subjects used the more affected arm combined with less affected arm restriction 5 days per week for 5 hours; both of these regimens were administered during a 10-week period) with that of a time-matched exercise program for the more affected arm or a no-treatment control regimen.
SUBJECTS: Thirty-five subjects with chronic stroke participated in the study.
METHODS: The Action Research Arm Test (ARAT), Fugl-Meyer Assessment of Motor Recovery After Stroke (FM), and Motor Activity Log (MAL) were administered to the subjects.
RESULTS: After intervention, significant differences were observed on the ARAT and MAL Amount of Use and Quality of Movement scales, all in favor of the mCIT group. DISCUSSION AND
CONCLUSION: The data affirm previous findings suggesting that this reimbursable, outpatient protocol increases more affected arm use and function. Magnitude of changes was consistent with those reported in more intense protocols, such as constraint-induced therapy.

Entities:  

Mesh:

Year:  2008        PMID: 18174447     DOI: 10.2522/ptj.20060029

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  50 in total

1.  The EXCITE Trial: analysis of "noncompleted" Wolf Motor Function Test items.

Authors:  Steven L Wolf; Paul A Thompson; Emily Estes; Timothy Lonergan; Rozina Merchant; Natasha Richardson
Journal:  Neurorehabil Neural Repair       Date:  2011-11-09       Impact factor: 3.919

2.  When will the evidence catch up with clinical practice?

Authors:  Cheryl A Cott; Julie Vaughan Graham; Karen Brunton
Journal:  Physiother Can       Date:  2011-08-10       Impact factor: 1.037

3.  Psychometric properties and administration of the wrist/hand subscales of the Fugl-Meyer Assessment in minimally impaired upper extremity hemiparesis in stroke.

Authors:  Stephen J Page; Peter Levine; Erinn Hade
Journal:  Arch Phys Med Rehabil       Date:  2012-07-01       Impact factor: 3.966

4.  Constraint-Induced Movement Therapy Compared to Dose-Matched Interventions for Upper-Limb Dysfunction in Adult Survivors of Stroke: A Systematic Review with Meta-analysis.

Authors:  Ted Stevenson; Leyda Thalman; Heather Christie; William Poluha
Journal:  Physiother Can       Date:  2012       Impact factor: 1.037

5.  Retention of the spacing effect with mental practice in hemiparetic stroke.

Authors:  Stephen J Page; Erinn M Hade; Juan Pang
Journal:  Exp Brain Res       Date:  2016-06-07       Impact factor: 1.972

6.  Emerging treatments for motor rehabilitation after stroke.

Authors:  Edward S Claflin; Chandramouli Krishnan; Sandeep P Khot
Journal:  Neurohospitalist       Date:  2015-04

7.  Protocol development, treatment fidelity, adherence to treatment, and quality control.

Authors:  Andrew C Persch; Stephen J Page
Journal:  Am J Occup Ther       Date:  2013 Mar-Apr

8.  Stimulation targeting higher motor areas in stroke rehabilitation: A proof-of-concept, randomized, double-blinded placebo-controlled study of effectiveness and underlying mechanisms.

Authors:  David A Cunningham; Nicole Varnerin; Andre Machado; Corin Bonnett; Daniel Janini; Sarah Roelle; Kelsey Potter-Baker; Vishwanath Sankarasubramanian; Xiaofeng Wang; Guang Yue; Ela B Plow
Journal:  Restor Neurol Neurosci       Date:  2015       Impact factor: 2.406

9.  Constraint-induced movement therapy for rehabilitation of arm dysfunction after stroke in adults: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-11-01

10.  Comparing unilateral and bilateral upper limb training: the ULTRA-stroke program design.

Authors:  A Lex E Q van Delden; C Lieke E Peper; Jaap Harlaar; Andreas Daffertshofer; Nienke I Zijp; Kirsten Nienhuys; Peter Koppe; Gert Kwakkel; Peter J Beek
Journal:  BMC Neurol       Date:  2009-11-06       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.